DMCC Speciality Chemicals Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025, pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board of Directors approved the results and several key corporate governance decisions during their meeting held on February 6, 2026.

Financial Performance Highlights

DMCC Speciality Chemicals delivered strong revenue growth in Q3FY26 across both standalone and consolidated operations, though profitability faced pressure due to elevated commodity prices and margin compression.

Consolidated Performance Overview

For the nine months ended December 31, 2025, the company reported consolidated revenue of ₹403.94 crore compared to ₹306.08 crore in the corresponding period of the previous year, representing growth of 31.97%. Net profit for the nine-month period stood at ₹19.67 crore versus ₹15.06 crore in the previous year, marking an increase of 30.68%.

Standalone Results

Operational Performance and Market Dynamics

During Q3FY26, the company recorded healthy topline growth driven by continuity in the Boron business and improved realisations in the commodity chemicals segment. The operational mix showed domestic revenues contributing 86% while exports accounted for 14% of total sales.

Business Segment Performance

Commodity prices remained elevated during the quarter, particularly sulphur, which is a key raw material. The company successfully passed through price increases to customers, protecting absolute profitability, though higher revenue base from elevated commodity prices led to margin percentage moderation.

Key Board Decisions and Corporate Governance

The Board of Directors approved several significant corporate governance matters during their meeting held on February 6, 2026.

Management Re-appointment

The board also approved remuneration enhancement for Shri Kuldeep Kumar Tiwari, Executive Director (Operations), amendments to Memorandum and Articles of Association, and postal ballot authorization for shareholder approvals.

Strategic Developments and Outlook

A key positive development has been the resumption of Boron operations, which contributed partially during the quarter but has now returned to normal levels. At its present scale, the Boron business has potential to generate annual revenues in the range of ₹125 to ₹150 crore, providing meaningful diversification to the company's portfolio.

The company continues strategic efforts to reduce geographic concentration by gaining traction in Latin American markets, helping mitigate subdued demand in Europe. The solar power project at Roha, along with waste heat recovery and cogeneration facilities at Roha and Dahej, now contribute over 80% of the company's energy requirements, strengthening cost efficiency and environmental performance.

DMCC Specialty Chemicals has announced a key board appointment, naming Ms. Saloni Jhaveri as an independent director. The appointment marks a significant addition to the company's governance structure as it continues to strengthen its leadership team.

Board Appointment Details

The company has provided specific details regarding the new directorship appointment:

Strategic Governance Enhancement

The appointment of Ms. Saloni Jhaveri as an independent director represents the company's commitment to maintaining robust corporate governance practices. Independent directors play a crucial role in providing objective oversight and bringing diverse perspectives to board deliberations.

Future Implementation

With the appointment scheduled to take effect from January 10, 2026, DMCC Specialty Chemicals is planning ahead for its board composition. The five-year term provides stability and continuity for the company's governance framework, ensuring consistent independent oversight during this period.

This board appointment reflects the company's proactive approach to corporate governance and its focus on building a strong leadership foundation for future operations.